Your browser does not support javascript

Welcome to Abattis Bioceuticals


Please note that the stock symbol has changed to ATT as of February 21, 2014


Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal and adult marijuana markets in North America. The company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions by supplying and partnering with companies to employ its vertical growing systems, extraction equipment/technology, and strategic marketing support to licensed growers and dispensaries. The company also has an extensive pipeline of high-quality products and Intellectual Property for the rapidly expanding botanical drug market. We follow strict Standard Operating Protocols and adhere to the Law's of Canada and Foreign Jurisdictions.

Recent News